Search
for
Sort by
Research 391–420 of 499
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Photobiomodulation for the management of hair loss
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Dermatotoxicology of microneedles (MNs) in man
- JAK inhibition decreases the autoimmune burden in Down syndrome
- A Comprehensive Review of Acne Vulgaris
- Alopecia Areata and Dexamethasone Mini-Pulse Therapy, A Prospective Cohort: Real World Evidence and Factors Related to Successful Response
- A Comparative Study of Oral Cyclosporine and Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata
- Alopecia areata: Part 2: treatment.
- Discoid lupus erythematosus successfully treated with deucravacitinib
- Toxicity of repeated oral intake of organic selenium, inorganic selenium, and selenium nanoparticles: A review
- Epidemiology of Cosmetic Procedures: An Update for Dermatologists
- Outbreak of thallium poisoning among Iraqi patients
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Skin manifestations associated with systemic diseases – Part I
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
- Weekly azathioprine pulse versus betamethasone oral mini-pulse in the treatment of moderate-to-severe alopecia areata
- Non‐Facial Skin Rejuvenation of the Neck, Chest, and Hands. Part One: Using Injections
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Malassezia infection: is there any chance or necessity in refractory acne?
- Cosmetic adverse effects of antiseizure medications; A systematic review